Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.
Oregon U.S. Sen. Ron Wyden again blasted the Trump administration on Monday over its proposed drug pricing plan.
Rep. Rob Nosse, D-Portland, touted his aggressive and innovative approach to tackling uncontrolled pharmaceutical costs on Thursday, calling on Oregon to lead where Congress has failed and other state-based reforms have fallen short.
OPINION -- In recent months, Americans have seen growing evidence of failure within the Affordable Care Act.